Skip to content

Study at Cambridge
About the University
Research at Cambridge

Services
About
Stories & Events
- News
- Events
- Insights
- Case Studies
- Videos
Contact

Search

Featured news

Cambridge Enterprise opens London office to underline global ambition for university innovation

Read more

Cambridge Enterprise London Office

News

Filter by year
Filter by category

Semarion's Tarun Vemulkar (CTO) and Jeroen Verheyen (CEO)

Cambridge spin-out Semarion raises £2.14m to commercialise cell assaying platform

22 February 2022

Dr Xavier Moya, co-founder Barocal

Zero-carbon refrigeration pioneer Barocal secures £1.3m funding to explore heating systems

15 February 2022

abstract; reflective surfaces and horizon

Cambridge spin-out secures £2.5m seed round for transformational genomic data management tech

01 February 2022

Cambridge Enterprise joins ecosystem partners for The Cambridge Carbon Challenge 2022

28 January 2022

2021 Annual Review reports success for Cambridge Enterprise

27 January 2022

‘Dark genome’ research licensed to start-up NonExomics published in Molecular Psychiatry

23 December 2021

Green banana fruits on tree for Cavendish banana disease research

Research supported by Cambridge Enterprise and Ceres Agri-Tech published in Nature

22 December 2021

Accelerated Materials wins The Chris Abell Postdoc Business Plan Competition

16 November 2021

Cambridge Enterprise-led Ceres Agri-Tech launches first three spin-outs

26 October 2021

Daniel Summerbell, Buffy Price, Sherif Elsayed-Ali, Aidan O’Sullivan. CarbonRe founders (Reducing Cement CO₂ Emissions)

Cambridge Enterprise invests in Carbon Re, start-up cutting CO₂ emissions by gigatonnes

20 October 2021

Echion founders Dr Alex Groombridge, CTO and Jean de La Verpilliere, CEO

University spin-out Echion Technologies raises £10m in Series A investment round

Cambridge spin-out Porotech raises £3m for new generation of microdisplays

Cambridge joins 11 other universities to launch impact investment fund

Pipette for Apollo Therapeutics launch

Apollo Therapeutics launches as multinational company

Dr Diarmuid O'Brien, CE designate, Cambridge Enterprise

The University of Cambridge announces appointment of Dr Diarmuid O’Brien as new Chief Executive for Cambridge Enterprise

iKVA management

University of Cambridge spin-out iKVA secures £1.5m seed funding

145-160 of 570

Page of 36

Contact us

Cambridge Enterprise 
University of Cambridge
Hauser Forum 
3 Charles Babbage Road
Cambridge CB3 0GT

+44 (0) 1223 760339

Company

Company information
Structure and Governance
Freedom of Information
Privacy
Cookies
Terms of use
Accessibility